Vion initiates phase I trial of Tapet with immune system modulation.
D001428:Bacterial Vaccines; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*
D001428:Bacterial Vaccines; D007166:Immunosuppressive Agents; C465023:VNP 20009; D014613:Vaccines, Attenuated